• LAST PRICE
    0.0500
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (25.0000%)
  • Bid / Lots
    0.0450/ 247
  • Ask / Lots
    0.0550/ 41
  • Open / Previous Close
    0.0450 / 0.0400
  • Day Range
    Low 0.0350
    High 0.0500
  • 52 Week Range
    Low 0.0250
    High 0.2000
  • Volume
    618,713
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.04
TimeVolumeNUMI
09:32 ET570000.045
09:35 ET2160000.04
09:39 ET20000.035
09:51 ET10000.04
10:02 ET10000.035
10:06 ET310000.04
10:26 ET150000.04
11:23 ET100000.04
11:38 ET150000.045
12:35 ET150000.045
01:06 ET20000.045
01:11 ET20000.04
02:25 ET200000.045
02:27 ET960000.045
02:57 ET400000.045
03:08 ET70000.05
03:14 ET20000.05
03:21 ET10000.045
03:30 ET150000.05
03:57 ET40000.05
04:00 ET640000.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaNUMI
Numinus Wellness Inc
12.9M
-0.6x
---
CanadaMPH
Medicure Inc
9.2M
-3.5x
---
CanadaAVCN
Avicanna Inc
27.9M
-3.7x
---
CanadaMBX
Microbix Biosystems Inc
42.0M
8.1x
---
CanadaCSCI
COSCIENS Biopharma Inc
15.5M
-0.4x
---
CanadaSZLS
StageZero Life Sciences Ltd
4.9M
0.0x
---
As of 2024-11-22

Company Information

Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.

Contact Information

Headquarters
393 Laurier Ave WMONTREAL, QC, Canada H2V 2K3
Phone
604-329-2079
Fax
604-329-2079

Executives

Chairman of the Board, Chief Executive Officer
Payton Nyquvest
President, Chief Operating Officer, Director
Michael Tan
Interim Chief Financial Officer
Melony Valleau
Senior Vice President - Clinic Operations
Jason Lapensee
Chief Scientific Officer, Chief Medical Officer
Paul Thielking

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$16.1M
Revenue (TTM)
$20.1M
Shares Outstanding
322.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.91
EPS
$-0.09
Book Value
$0.05
P/E Ratio
-0.6x
Price/Sales (TTM)
0.8
Price/Cash Flow (TTM)
---
Operating Margin
-106.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.